SEC Comment Letter for Harmony Biosciences Holdings, Inc. (HRMY) (CIK 0001802665) (HRMY) — Apr 15, 2025
Harmony Biosciences Holdings, Inc. (HRMY) (CIK 0001802665)
Date: April 15, 2025 · CIK: 0001802665 · Accession: 0000000000-25-003969
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 001-39450
Letter
Re: Harmony Biosciences Holdings, Inc. Form10-K for Fiscal Year Ended December 31 , 2024 File No. 001-39450 Dear Sandip Kapadia:
April 15, 2025
Sandip Kapadia Chief Financial Officer Harmony Biosciences Holdings, Inc. 630 W. Germantown Pike, Suite 215 Plymouth Meeting, PA 19462
We have completed our review of your filings. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation
Finance
Office of Life Sciences
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> April 15, 2025 Sandip Kapadia Chief Financial Officer Harmony Biosciences Holdings, Inc. 630 W. Germantown Pike, Suite 215 Plymouth Meeting, PA 19462 Re: Harmony Biosciences Holdings, Inc. Form10-K for Fiscal Year Ended December 31 , 2024 File No. 001-39450 Dear Sandip Kapadia: We have completed our review of your filings. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences </TEXT> </DOCUMENT>